Evidence map›Paper›PMID 36297010›Full record

ReviewNutrients2022

CoQ

Gaia Gherardi, Giovanni Corbioli, Filippo Ruzza, Rosario Rizzuto

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gaia GherardiDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0001-6212-3477
Giovanni CorbioliSolgar Italia Multinutrient Spa, Via Prima Strada 23/3, 35129 Padova, Italy.
Filippo RuzzaSolgar Italia Multinutrient Spa, Via Prima Strada 23/3, 35129 Padova, Italy.
Rosario RizzutoDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.
University of Padua · IT

Funding

AIRC Programma di ricerca 5 per Mille 2019 22759Bando Ricerca Scientifica di Eccellenza 2017 della Fondazione Cassa di Risparmio di Padova e Rovigo Eccellenza2017Bando Ricerca Scientifica di Eccellenza 2018 della Fondazione Cassa di Risparmio di Padova e Rovigo Eccellenza2018Dept. of Biomedical sciences, UNIPD GHER_BIRD2222_01MIUR PRIN 2020 2020R2BP2E_002Progetto ricerca sanitaria finalizzata Rep. 100/2019 RF-2016-02363566
6 · The paper itself

Abstract

Mitochondria participate in the maintenance of cellular homeostasis. Firstly, mitochondria regulate energy metabolism through oxidative phosphorylation. In addition, they are involved in cell fate decisions by activating the apoptotic intrinsic pathway. Finally, they work as intracellular signaling hubs as a result of their tight regulation of ion and metabolite concentrations and other critical signaling molecules such as ROS. Aging is a multifactorial process triggered by impairments in different cellular components. Among the various molecular pathways involved, mitochondria are key regulators of longevity. Indeed, mitochondrial deterioration is a critical signature of the aging process. In this scenario, we will focus specifically on the age-related decrease in CoQ levels, an essential component of the electron transport chain (ETC) and an antioxidant, and how CoQ supplementation could benefit the aging process. Generally, any treatment that improves and sustains mitochondrial functionality is a good candidate to counteract age-related mitochondrial dysfunctions. In recent years, heightened attention has been given to natural compounds that modulate mitochondrial function. One of the most famous is resveratrol due to its ability to increase mitochondrial biogenesis and work as an antioxidant agent. This review will discuss recent clinical trials and meta-analyses based on resveratrol and CoQ supplementation, focusing on how these compounds could improve mitochondrial functionality during aging.

Indexed as

AntioxidantsMitochondriaOxidative PhosphorylationOxidative StressReactive Oxygen SpeciesResveratrolAntioxidantsReactive Oxygen SpeciesResveratrolagingcoenzymeQ10mitochondriaresveratrol

Identifiers

PMID36297010
PMCPMC9611139
OpenAlexW4306399041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.